US equities |
MU $934.27 ▲+0.00% INTC $92.07 ▲+0.00% SNDK $1,330.05 ▲+0.00% AMZN $243.79 ▲+0.00% NVDA $213.66 ▲+0.00% AAPL $348.91 ▲+0.00% GOOGL $283.82 ▲+0.00% MSFT $530.14 ▲+0.00%
FinancialContent

Celularity Inc. - Warrant (NQ:CELUW)

0.0019 UNCHANGED
Last Price Updated: 3:57 PM EDT, Jul 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Celularity Inc. - Warrant

News headline image
Celularity Announces Naveen Jain to Join Board of Directors
Viome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health 
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity Provides Update Regarding Nasdaq Listing Compliance
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
Company presents results from in vivo studies of PT-CD16VS, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells, in combination with various monoclonal... 
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity Inc. to Host Investor and Analyst Research & Development Day
Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress 
From Celularity Inc.
Via GlobeNewswire
News headline image
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
From Celularity Inc.
Via GlobeNewswire